GIM
ITRM

Granahan Investment Management’s Iterum Therapeutics ITRM Stock Holding History

Granahan Investment Management’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-16,075
Closed -$653K – 200
2020
Q1 		$653K Sell
16,075
-223
-1% -$9.38K 0.04% 169
2019
Q4 		$1.1M Buy
16,298
+150
+0.9% +$7.32K 0.05% 156
2019
Q3 		$1.4M Buy
16,148
+624
+4% +$60.8K 0.08% 151
2019
Q2 		$1.6M Buy
15,524
+71
+0.5% +$7.89K 0.08% 153
2019
Q1 		$1.84M Sell
15,453
-967
-6% -$88.7K 0.1% 155
2018
Q4 		$1.23M Sell
16,420
-294
-2% -$27.8K 0.09% 154
2018
Q3 		$1.66M Buy
16,714
+657
+4% +$85.8K 0.09% 166
2018
Q2 		$2.57M Buy
+16,057
New +$2.9M 0.15% 145

Other funds holding ITRM

CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.76B AUM 62.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ML
McAdam LLC Philadelphia, Pennsylvania $2.59B AUM 21.24% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
CCMW
Cypress Capital Management (Wyoming) Sheridan, Wyoming $120M AUM 63.01% 1-Year Est. Return

Granahan Investment Management's ITRM Position: Q2 2020 in Review

Granahan Investment Management sold out of Iterum Therapeutics (ITRM) in Q2 2020, closing a stake of 16,075 shares — an estimated $653K sold.

Granahan Investment Management first reported a position in ITRM in Q2 2018 and held it in 8 quarters. The position peaked at $2.57M in Q2 2018. 10 funds tracked by Wall St. Rank hold ITRM as of Q2 2020.

  • Granahan Investment Management reported no remaining Iterum Therapeutics position as of Q2 2020 after selling out during the quarter.
  • Granahan Investment Management sold 16,075 Iterum Therapeutics shares in Q2 2020, an estimated $653K.
  • Granahan Investment Management first reported a position in Iterum Therapeutics in Q2 2018 and held it in 8 quarters.
  • Granahan Investment Management's Iterum Therapeutics position peaked at $2.57M in Q2 2018.
  • 10 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q2 2020.

Based on Granahan Investment Management's 13F filing for Q2 2020, filed 14 Aug 2020.